190 related articles for article (PubMed ID: 37540256)
1. Characterization of tumor microenvironment infiltration and therapeutic responses of cell cycle-related genes' signature in breast cancer.
Wu H; Chen Y; Li M; Chen Z; Liu J; Lai G
J Cancer Res Clin Oncol; 2023 Nov; 149(15):13889-13904. PubMed ID: 37540256
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive
Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
Front Immunol; 2022; 13():931906. PubMed ID: 35958598
[TBL] [Abstract][Full Text] [Related]
3. Establishment and validation of an aging-related risk signature associated with prognosis and tumor immune microenvironment in breast cancer.
Wang Z; Liu H; Gong Y; Cheng Y
Eur J Med Res; 2022 Dec; 27(1):317. PubMed ID: 36581948
[TBL] [Abstract][Full Text] [Related]
4. Integrative transcriptional characterization of cell cycle checkpoint genes promotes clinical management and precision medicine in bladder carcinoma.
Shi WW; Guan JZ; Long YP; Song Q; Xiong Q; Qin BY; Ma ZQ; Hu Y; Yang B
Front Oncol; 2022; 12():915662. PubMed ID: 36033441
[TBL] [Abstract][Full Text] [Related]
5. Identification of a combined apoptosis and hypoxia gene signature for predicting prognosis and immune infiltration in breast cancer.
Ren X; Cui H; Wu J; Zhou R; Wang N; Liu D; Xie X; Zhang H; Liu D; Ma X; Dang C; Kang H; Lin S
Cancer Med; 2022 Oct; 11(20):3886-3901. PubMed ID: 35441810
[TBL] [Abstract][Full Text] [Related]
6. A Novel Aging-Related Prognostic lncRNA Signature Correlated with Immune Cell Infiltration and Response to Immunotherapy in Breast Cancer.
Liu Z; Ren C; Cai J; Yin B; Yuan J; Ding R; Ming W; Sun Y; Li Y
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110517
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
Front Immunol; 2022; 13():891175. PubMed ID: 35990668
[TBL] [Abstract][Full Text] [Related]
8. Pyroptosis-related molecular classification and immune microenvironment infiltration in breast cancer: A novel therapeutic target.
Luo J; Lai J
J Cell Mol Med; 2022 Apr; 26(8):2259-2272. PubMed ID: 35233921
[TBL] [Abstract][Full Text] [Related]
9. Characterization of protein-based risk signature to predict prognosis and evaluate the tumor immune environment in breast cancer.
Qing X; Yuan C; Wang K
Breast Cancer; 2023 May; 30(3):424-435. PubMed ID: 36732487
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of nicotinamide metabolism-related signature for predicting prognosis and immunotherapy response in breast cancer.
Cui H; Ren X; Dai L; Chang L; Liu D; Zhai Z; Kang H; Ma X
Front Immunol; 2023; 14():1145552. PubMed ID: 36969219
[TBL] [Abstract][Full Text] [Related]
11. Unfolded protein response signature unveils novel insights into breast cancer prognosis and tumor microenvironment.
Zhou N; Kong D; Lin Q; Yang X; Zhou D; Lou L; Huang F
Cancer Genet; 2023 Aug; 276-277():17-29. PubMed ID: 37343507
[TBL] [Abstract][Full Text] [Related]
12. Derivation and Comprehensive Analysis of Aging Patterns in Patients with Bladder Cancer.
Wang B; Tong F; Zhai C; Wang L; Liu Y; Wang J
Dis Markers; 2021; 2021():3385058. PubMed ID: 34721733
[TBL] [Abstract][Full Text] [Related]
13. A novel circadian cycle-related gene signature for prognosis prediction of patients with breast cancer.
Hu Y; Fan S; Zhu Y; Xie X
Medicine (Baltimore); 2023 May; 102(18):e33718. PubMed ID: 37144994
[TBL] [Abstract][Full Text] [Related]
14. A novel lactate metabolism-related signature predicts prognosis and tumor immune microenvironment of breast cancer.
Zhang Z; Fang T; Lv Y
Front Genet; 2022; 13():934830. PubMed ID: 36171887
[No Abstract] [Full Text] [Related]
15. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
Front Genet; 2022; 13():919389. PubMed ID: 35783281
[No Abstract] [Full Text] [Related]
16. Construction of a breast cancer prognosis model based on alternative splicing and immune infiltration.
Zhang D; Lu W; Zhuo Z; Mei H; Wu X; Cui Y
Discov Oncol; 2022 Aug; 13(1):78. PubMed ID: 35988113
[TBL] [Abstract][Full Text] [Related]
17. The biomarkers related to immune infiltration to predict distant metastasis in breast cancer patients.
Ren C; Gao A; Fu C; Teng X; Wang J; Lu S; Gao J; Huang J; Liu D; Xu J
Front Genet; 2023; 14():1105689. PubMed ID: 36911401
[No Abstract] [Full Text] [Related]
18. Identification of cuproptosis-related long noncoding RNA signature for predicting prognosis and immunotherapy response in bladder cancer.
Huang G; Huang Y; Zhang C; Jiang Y; Ye Z; He C; Yu F; Chen Z; Xi X
Sci Rep; 2022 Dec; 12(1):21386. PubMed ID: 36496537
[TBL] [Abstract][Full Text] [Related]
19. A combined hypoxia and immune gene signature for predicting survival and risk stratification in triple-negative breast cancer.
Yang X; Weng X; Yang Y; Zhang M; Xiu Y; Peng W; Liao X; Xu M; Sun Y; Liu X
Aging (Albany NY); 2021 Aug; 13(15):19486-19509. PubMed ID: 34341184
[TBL] [Abstract][Full Text] [Related]
20. A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer.
Wang L; Xiao K; Dong Z; Meng T; Cheng X; Xu Y
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10543-10559. PubMed ID: 37291405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]